Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 18:12:631061.
doi: 10.3389/fgene.2021.631061. eCollection 2021.

Assessment of Causal Direction Between Gut Microbiota and Inflammatory Bowel Disease: A Mendelian Randomization Analysis

Zi-Jia Zhang  1   2   3 , Hong-Lei Qu  4 , Na Zhao  3 , Jing Wang  3 , Xiu-Yan Wang  3 , Rong Hai  3   5 , Bin Li  1
Affiliations

Assessment of Causal Direction Between Gut Microbiota and Inflammatory Bowel Disease: A Mendelian Randomization Analysis

Zi-Jia Zhang et al. Front Genet. .

Abstract

Background: Recent studies have shown that the gut microbiota is closely related to the pathogenesis of Inflammatory Bowel Disease (IBD), but the causal nature is largely unknown. The purpose of this study was to assess the causal relationship between intestinal bacteria and IBD and to identify specific pathogenic bacterial taxa via the Mendelian randomization (MR) analysis.

Materials and methods: MR analysis was performed on genome-wide association study (GWAS) summary statistics of gut microbiota and IBD. Specifically, the TwinsUK microbiota GWAS (N = 1,126 twin pairs) was used as exposure. The UK inflammatory bowel disease (UKIBD) and the Understanding Social Program (USP) study GWAS (N = 48,328) was used as discovery outcome, and the British IBD study (N = 35,289) was used as replication outcome. SNPs associated with bacteria abundance at the suggestive significance level (α = 1.0 × 10-5) were used as instrumental variables. Bacteria were grouped into families and genera.

Results: In the discovery sample, a total of 30 features were available for analysis, including 15 families and 15 genera. Three features were nominally significant, including one family (Verrucomicrobiaceae, 2 IVs, beta = -0.04, p = 0.05) and two genera (Akkermansia, 2 IVs, beta = 0.04, p = 0.05; Dorea, 2 IVs, beta = -0.07, p = 0.04). All of them were successfully replicated in the replication sample (Verrucomicrobiaceae and Akkermansia P replication = 0.02, Dorea P replication = 0.01) with consistent effect direction.

Conclusion: We identified specific pathogenic bacteria features that were causally associated with the risk of IBD, thus offering new insights into the prevention and diagnosis of IBD.

Keywords: causal relationship; gut microbiota; inflammatory bowel disease; mendelian randomization; ulcerative colitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Diagrammatic description of MR analysis in the discovery and replication. (A) The whole workflow of MR analysis. (B) The main results and the change in the number of SNPs.
See this image and copyright information in PMC

References

    1. Backhed F., Roswall J., Peng Y., Feng Q., Jia H., Kovatcheva-Datchary P., et al. (2015). Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 17 852. 10.1016/j.chom.2015.05.012 - DOI - PubMed
    1. Bajer L., Kverka M., Kostovcik M., Macinga P., Dvorak J., Stehlikova Z., et al. (2017). Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis. World J. Gastroenterol. 23 4548–4558. 10.3748/wjg.v23.i25.4548 - DOI - PMC - PubMed
    1. Bengtson M. B., Solberg C., Aamodt G., Sauar J., Jahnsen J., Moum B., et al. (2009). Familial aggregation in Crohn’s disease and ulcerative colitis in a Norwegian population-based cohort followed for ten years. J. Crohns Colitis 3 92–99. 10.1016/j.crohns.2008.11.002 - DOI - PubMed
    1. Bernstein C. N., Wajda A., Svenson L. W., MacKenzie A., Koehoorn M., Jackson M., et al. (2006). The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am. J. Gastroenterol. 101 1559–1568. - PubMed
    1. Bowden J., Davey Smith G., Burgess S. (2015). Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44 512–525. 10.1093/ije/dyv080 - DOI - PMC - PubMed

LinkOut - more resources